Lenox Wealth Advisors’s Affimed AFMD Stock Holding History

Lenox Wealth Advisors’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-500	Closed	-$28K	–	754
2021 Q4	$28K	Buy	+500	New	+$30.9K	﹤0.01%	340

Other funds holding AFMD

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Lenox Wealth Advisors's AFMD Position: Q1 2022 in Review

Lenox Wealth Advisors sold out of Affimed (AFMD) in Q1 2022, closing a stake of 500 shares — an estimated $28K sold.

Lenox Wealth Advisors first reported a position in AFMD in Q4 2021 and held it in 1 quarter. The position peaked at $28K in Q4 2021. 118 funds tracked by Wall St. Rank hold AFMD as of Q1 2022.

Lenox Wealth Advisors reported no remaining Affimed position as of Q1 2022 after selling out during the quarter.
Lenox Wealth Advisors sold 500 Affimed shares in Q1 2022, an estimated $28K.
Lenox Wealth Advisors first reported a position in Affimed in Q4 2021 and held it in 1 quarter.
Lenox Wealth Advisors's Affimed position peaked at $28K in Q4 2021.
118 funds tracked by Wall St. Rank held Affimed as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.